TLR4-Independent upregulation of activation markers in mouse B lymphocytes infected by HRSV

Molecular Immunology

Volumn 47, Issue 9, 2010, Pages 1802-1807

  Rico, Miguel Ángel ^a   Infantes, Susana ^a   Ramos, Manuel ^a   Trento, Alfonsina ^b   Johnstone, Carolina ^a   Melero, José Antonio ^b   Del Val, Margarita ^a,c   Lopez Daniel D ^a  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

B lymphocyte; FACS; Respiratory models; Viral immunity

Indexed keywords

CD86 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE ACTIVATION; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; HUMORAL IMMUNITY; MACROPHAGE ACTIVATION; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; UPREGULATION; VIRUS CELL INTERACTION; VIRUS INFECTION; VIRUS INFECTIVITY; WILD TYPE;

ANIMALS; ANTIGENS, CD86; B-LYMPHOCYTES; CELL SEPARATION; CELLS, CULTURED; FEMALE; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS II; HOST-PATHOGEN INTERACTIONS; HUMANS; LYMPHOCYTE ACTIVATION; MICE; MICE, KNOCKOUT; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; TOLL-LIKE RECEPTOR 4; UP-REGULATION;

HUMAN RESPIRATORY SYNCYTIAL VIRUS; HYDRANGEA RINGSPOT VIRUS;

EID: 77952316858     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2010.02.019     Document Type: Article

References (39)

1. Barton G.M., Medzhitov R. Toll-like receptors and their ligands. Curr. Top. Microbiol. Immunol. 2002, 270:81-92.
2. Bartz H., Turkel O., Hoffjan S., Rothoeft T., Gonschorek A., Schauer U. Respiratory syncytial virus decreases the capacity of myeloid dendritic cells to induce interferon-gamma in naive T cells. Immunology 2003, 109:49-57.
3. Becker S., Quay J., Soukup J. Cytokine (tumor necrosis factor, IL-6, and IL-8) production by respiratory syncytial virus-infected human alveolar macrophages. J. Immunol. 1991, 147:4307-4312.
4. Collins P.L., Chanock R.M., Murphy B.R. Respiratory syncytial virus. Fields Virology 2007, 1443-1486. Lippincott Williams & Wilkins.
5. Ehl S., Bischoff R., Ostler T., Vallbracht S., Schulte-Monting J., Poltorak A., Freudenberg M. The role of Toll-like receptor 4 versus interleukin-12 in immunity to respiratory syncytial virus. Eur. J. Immunol. 2004, 34:1146-1153.
6. Falsey A.R., Hennessey P.A., Formica M.A., Cox C., Walsh E.E. Respiratory syncytial virus infection in elderly and high-risk adults. N. Engl. J. Med. 2005, 352:1749-1759.
7. Franke-Ullmann G., Pfortner C., Walter P., Steinmuller C., Lohmann-Matthes M.L., Kobzik L., Freihorst J. Alteration of pulmonary macrophage function by respiratory syncytial virus infection in vitro. J. Immunol. 1995, 154:268-280.
8. García-Barreno B., Palomo C., Peñas C., Delgado T., Pérez-Breña P., Melero J.A. Marked differences in the antigenic structure of human respiratory syncytial virus F and G glycoproteins. J. Virol. 1989, 63:925-932.
9. Garofalo R., Mei F., Espejo R., Ye G., Haeberle H., Baron S., Ogra P.L., Reyes V.E. Respiratory syncytial virus infection of human respiratory epithelial cells up-regulates class I MHC expression through the induction of IFN-beta and IL-1 alpha. J. Immunol. 1996, 157:2506-2513.
10. Hall C.B. Respiratory syncytial virus and parainfluenza virus. N. Engl. J. Med. 2001, 344:1917-1928.
11. Hallak L.K., Spillmann D., Collins P.L., Peeples M.E. Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection. J. Virol. 2000, 74:10508-10513.
12. Han L.L., Alexander J.P., Anderson L.J. Respiratory syncytial virus pneumonia among the elderly: an assessment of disease burden. J. Infect. Dis. 1999, 179:25-30.
13. Haynes L.M., Moore D.D., Kurt-Jones E.A., Finberg R.W., Anderson L.J., Tripp R.A. Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus. J. Virol. 2001, 75:10730-10737.
14. Hornung V., Schlender J., Guenthner-Biller M., Rothenfusser S., Endres S., Conzelmann K.K., Hartmann G. Replication-dependent potent IFN-alpha induction in human plasmacytoid dendritic cells by a single-stranded RNA virus. J. Immunol. 2004, 173:5935-5943.
15. Huang S., Wei W., Yun Y. Upregulation of TLR7 and TLR3 gene expression in the lung of respiratory syncytial virus infected mice. Wei Sheng Wu Xue Bao 2009, 49:239-245.
16. Huber M., Kalis C., Keck S., Jiang Z., Georgel P., Du X., Shamel L., Sovath S., Mudd S., Beutler B., Galanos C., Freudenberg M.A. R-form LPS, the master key to the activation of TLR4/MD-2-positive cells. Eur. J. Immunol. 2006, 36:701-711.
17. Ison M.G., Hayden F.G. Viral infections in immunocompromised patients: what's new with respiratory viruses?. Curr. Opin. Infect. Dis. 2002, 15:355-367.
18. Jaovisidha P., Peeples M.E., Brees A.A., Carpenter L.R., Moy J.N. Respiratory syncytial virus stimulates neutrophil degranulation and chemokine release. J. Immunol. 1999, 163:2816-2820.
19. Jiang Z., Georgel P., Du X., Shamel L., Sovath S., Mudd S., Huber M., Kalis C., Keck S., Galanos C., Freudenberg M., Beutler B. CD14 is required for MyD88-independent LPS signaling. Nat. Immunol. 2005, 6:565-570.
20. Kurt-Jones E.A., Popova L., Kwinn L., Haynes L.M., Jones L.P., Tripp R.A., Walsh E.E., Freeman M.W., Golenbock D.T., Anderson L.J., Finberg R.W. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat. Immunol. 2000, 1:398-401.
21. Machida K., Cheng K.T., Sung V.M., Levine A.M., Foung S., Lai M.M. Hepatitis C virus induces toll-like receptor 4 expression, leading to enhanced production of beta interferon and interleukin-6. J. Virol. 2006, 80:866-874.
22. Merlin T., Sing A., Nielsen P.J., Galanos C., Freudenberg M.A. Inherited IL-12 unresponsiveness contributes to the high LPS resistance of the Lps(d) C57BL/10ScCr mouse. J. Immunol. 2001, 166:566-573.
23. Midulla F., Huang Y.T., Gilbert I.A., Cirino N.M., McFadden E.R., Panuska J.R. Respiratory syncytial virus infection of human cord and adult blood monocytes and alveolar macrophages. Am. Rev. Respir. Dis. 1989, 140:771-777.
24. Murawski M.R., Bowen G.N., Cerny A.M., Anderson L.J., Haynes L.M., Tripp R.A., Kurt-Jones E.A., Finberg R.W. Respiratory syncytial virus activates innate immunity through Toll-like receptor 2. J. Virol. 2009, 83:1492-1500.
25. Nomura F., Akashi S., Sakao Y., Sato S., Kawai T., Matsumoto M., Nakanishi K., Kimoto M., Miyake K., Takeda K., Akira S. Cutting edge: endotoxin tolerance in mouse peritoneal macrophages correlates with down-regulation of surface toll-like receptor 4 expression. J. Immunol. 2000, 164:3476-3479.
26. Panuska J.R., Cirino N.M., Midulla F., Despot J.E., McFadden E.R., Huang Y.T. Productive infection of isolated human alveolar macrophages by respiratory syncytial virus. J. Clin. Invest. 1990, 86:113-119.
27. Peng S.L. Signaling in B cells via Toll-like receptors. Curr. Opin. Immunol. 2005, 17:230-236.
28. Poltorak A., He X., Smirnova I., Liu M.Y., Van Huffel C., Du X., Birdwell D., Alejos E., Silva M., Galanos C., Freudenberg M., Ricciardi-Castagnoli P., Layton B., Beutler B. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 1998, 282:2085-2088.
29. Rassa J.C., Meyers J.L., Zhang Y., Kudaravalli R., Ross S.R. Murine retroviruses activate B cells via interaction with toll-like receptor 4. Proc. Natl. Acad. Sci. U.S.A. 2002, 99:2281-2286.
30. Rico M.A., Trento A., Ramos M., Johnstone C., Del Val M., Melero J.A., Lopez D. Human respiratory syncytial virus infects and induces activation markers in mouse B lymphocytes. Immunol. Cell Biol. 2009, 87:344-350.
31. Shay D.K., Holman R.C., Roosevelt G.E., Clarke M.J., Anderson L.J. Bronchiolitis-associated mortality and estimates of respiratory syncytial virus-associated deaths among US children, 1979-1997. J. Infect. Dis. 2001, 183:16-22.
32. Streckert H.J., Philippou S., Riedel F. Detection of respiratory syncytial virus (RSV) antigen in the lungs of guinea pigs 6 weeks after experimental infection and despite of the production of neutralizing antibodies. Arch. Virol. 1996, 141:401-410.
33. Techaarpornkul S., Collins P.L., Peeples M.E. Respiratory syncytial virus with the fusion protein as its only viral glycoprotein is less dependent on cellular glycosaminoglycans for attachment than complete virus. Virology 2002, 294:296-304.
34. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Cox N., Anderson L.J., Fukuda K. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003, 289:179-186.
35. Thurau A.M., Streckert H.J., Rieger C.H., Schauer U. Increased number of T cells committed to IL-5 production after respiratory syncytial virus (RSV) infection of human mononuclear cells in vitro. Clin. Exp. Immunol. 1998, 113:450-455.
36. Wendt C.H., Hertz M.I. Respiratory syncytial virus and parainfluenza virus infections in the immunocompromised host. Semin. Respir. Infect. 1995, 10:224-231.
37. Werling D., Jann O.C., Offord V., Glass E.J., Coffey T.J. Variation matters: TLR structure and species-specific pathogen recognition. Trends Immunol. 2009, 30:124-130.
38. Wright S.D. CD14 and innate recognition of bacteria. J. Immunol. 1995, 155:6-8.
39. Yang R., Murillo F.M., Delannoy M.J., Blosser R.L., Yutzy W.H., Uematsu S., Takeda K., Akira S., Viscidi R.P., Roden R.B. B lymphocyte activation by human papillomavirus-like particles directly induces Ig class switch recombination via TLR4-MyD88. J. Immunol. 2005, 174:7912-7919.